Italia markets closed

BRAIN Biotech AG (0RFI.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
2,2300-0,5700 (-20,36%)
Alla chiusura: 09:02AM BST

BRAIN Biotech AG

Darmstädter Strasse 34-36
Zwingenberg 64673
49 62 51 9331 0

Impiegati a tempo pieno322

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Adriaan MoelkerChairman of the Management Board & CEO620kN/DN/D
Mr. Ulrich PutschCo-FounderN/DN/DN/D
Mr. Michael SchneidersCFO & Member of Management BoardN/DN/D1970
Dr. Ute DechertVice President of Human Resources & ProcessesN/DN/D1961
Dr. Jurgen EckConsultant392kN/D1962
Dr. Martin LangerMD & Executive VPN/DN/D1965
Dr. Alexander PelzerVP and Head of Research & Development - ZwingenbergN/DN/D1986
Mr. Robbert Michael HoekstraHead of Group FinanceN/DN/D1978
Mr. Paul ScholzTechnical Lead of Genome Editing DevelopmentN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.


BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. It also provides biocatalysts and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

Governance aziendale

L'ISS Governance QualityScore di BRAIN Biotech AG al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.